These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2511706)

  • 21. Development of an auxotrophic oral live Shigella flexneri vaccine.
    Lindberg AA; Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP
    Vaccine; 1988 Apr; 6(2):146-50. PubMed ID: 2838986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.
    Denchev V; Sumerska T; Marinova S; Vassilev T; Panova I; Linde K
    Acta Microbiol Hung; 1990; 37(4):359-66. PubMed ID: 2099082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin.
    Anderson RJ; Pasetti MF; Sztein MB; Levine MM; Noriega FR
    Vaccine; 2000 Apr; 18(21):2193-202. PubMed ID: 10717338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An increase in the immunogenicity of bacterial antigens under the influence of one of the derivatives of muramyl dipeptide].
    Britsina MV; Shepeleva IB; Baturo AP; Elkina SI; Kalina NG; Andronova TM; Ermolova EV; Zakharova NS; Ivanov VT; Sokolova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):43-5. PubMed ID: 1455969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunization of monkeys with polyvalent dysentery vaccine.
    Dhikidze EK; Kavtaradze KN; Krilova RI; Rauss K; Kétyi I; Vertényi A
    Acta Microbiol Acad Sci Hung; 1977; 24(1):7-12. PubMed ID: 412396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reaction of the hematopoietic system in mice to the administration of virulent and avirulent strains of Shigella flexneri 2A].
    Nikolaeva TN; Sanin AV; Belaia IuA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1987; (6):17-22. PubMed ID: 3304434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The optimization of the technology for culturing vaccinal strains of Shigella flexneri].
    Basnak'ian IA; Miriasova LV; Sokolova TV; Ian'kova MM; Kalina NG; Elkina SI; Sergeev VV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):6-10. PubMed ID: 8067146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of immunization with an enterobacterial vaccine on the rate of plating out of Shigella from the intestinal mucosa of mice orally infected].
    Apollonin AV; Elkina SI; Beĭlina VB; Likhoded VG; Sergeev VV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):24-8. PubMed ID: 3529760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulated Delayed
    Su H; Liu Q; Wang S; Curtiss R; Kong Q
    Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
    Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
    Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of production and control methods of live dysentery vaccine Vadizen (Shigella flexneri 2a T32-Istrati).
    Meitert T; Ciudin L; Pencu E; Tonciu M; Gheorghe G
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):357-67. PubMed ID: 6400311
    [No Abstract]   [Full Text] [Related]  

  • 34. [Protective properties of Proteus ribosomal vaccine].
    Ovetchin PV; Tsyganenko AIa
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):19-23. PubMed ID: 6367317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interrelation of virulent and avirulent (vaccinal) strains of Shigella flexneri 2A in long-term bacterial carriage in gnotobiotic rats].
    Belaia IuA; Chakhava OV; Bystrova SM; Shustrova NM; Popova LIu
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):82-9. PubMed ID: 6375221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and evaluation of a virG thyA double mutant of Shigella flexneri 2a as a candidate live-attenuated oral vaccine.
    Yoshikawa M; Sasakawa C; Okada N; Takasaka M; Nakayama M; Yoshikawa Y; Kohno A; Danbara H; Nariuchi H; Shimada H
    Vaccine; 1995; 13(15):1436-40. PubMed ID: 8578822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition.
    Mukhopadhaya A; Mahalanabis D; Khanam J; Chakrabarti MK
    Vaccine; 2003 Jun; 21(21-22):3043-50. PubMed ID: 12798648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotype conversion of a Shigella flexneri candidate vaccine strain via a novel site-specific chromosome-integration system.
    Guan S; Verma NK
    FEMS Microbiol Lett; 1998 Sep; 166(1):79-87. PubMed ID: 9741086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
    Kotloff KL; Losonsky GA; Nataro JP; Wasserman SS; Hale TL; Taylor DN; Newland JW; Sadoff JC; Formal SB; Levine MM
    Vaccine; 1995 Apr; 13(5):495-502. PubMed ID: 7639017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.